{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:38:34Z","timestamp":1793893114132,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010280","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T00:00:00Z","timestamp":1406246400000}}],"reference-count":55,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010280.pub2","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T14:02:30Z","timestamp":1406296950000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1002","volume":"2014","author":[{"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"first","affiliation":[{"name":"H. Lee Moffitt Cancer Center, Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation; Tampa Florida USA"},{"name":"American University of Beirut; Division of Hematology-Oncology and Bone Marrow Transplantation Program; Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mhaskar","sequence":"additional","affiliation":[{"name":"University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Reljic","sequence":"additional","affiliation":[{"name":"University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center, Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle B","family":"Perkins","sequence":"additional","affiliation":[{"name":"Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center; 12902 Magnolia Dr. Tampa Florida USA 33612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center, Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation; Tampa Florida USA"},{"name":"University of South Florida; USF Clinical Translational Science Institute, Departments of Medicine, Hematology and Health Outcome Research; 12901 Bruce B. Downs Boulevard, CMS 3057 Tampa Florida USA 33612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,25]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD010280.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1704647","article-title":"A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation","volume":"34","author":"Bolwell","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"Pt 1","key":"10.1002\/14651858.CD010280.pub2-BIB0002|cit2","first-page":"711a","article-title":"A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT","volume":"11","author":"Bolwell","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0003|cit3","unstructured":"Fauser A Linck D S-EK Bornhauser M Blau I Kroger M WH Ehninger G Mycophenolate mofetil in combination with cyclosporine A (CSA) +\/- prednisolone versus CsA, methotrexate +\/- prednisolone for the prophylaxis of acute graft-versus-host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase Onkologie 2006 115"},{"issue":"Pt 1","key":"10.1002\/14651858.CD010280.pub2-BIB0004|cit4","first-page":"716a","article-title":"Mycophenolate mofetil in combination with cyclosporine a (CSA) \u00b1 prednisolone versus CsA, methotrexate \u00b1 prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation - MMF, a new option in GvHD prophylaxis","volume":"11","author":"Kiehl","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD010280.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/S0041-1345(02)03489-9","article-title":"Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients","volume":"34","author":"Kiehl","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0006|cit6","first-page":"S151","article-title":"First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease","volume":"Suppl 1","author":"Kraut","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0007|cit7","first-page":"S177","article-title":"Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients","volume":"Suppl 2","author":"Kraut","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD010280.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2010.01.010","article-title":"A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis","volume":"16","author":"Perkins","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010280.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1704956","article-title":"Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings","volume":"35","author":"Neumann","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010280.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-0012.2008.00894.x","article-title":"Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies","volume":"23","author":"Ostronoff","year":"2009","journal-title":"Clinical Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD010280.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/bmt.2009.362","article-title":"MTX\u00a0or\u00a0mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings","volume":"45","author":"Pi\u00f1ana","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0012|cit12","first-page":"507","article-title":"Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation","volume":"82","author":"Wang","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0013|cit13","unstructured":"NCT00563589 Mycophenolate mofetil for the prophylaxis of graft-versus-host disease in high risk allogeneic stem cell transplantation clinicaltrials.gov\/ct2\/show\/NCT00563589"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0014|cit14","unstructured":"NCT00928018 Tacrolimus\/sirolimus\/methotrexate versus tacrolimus\/methotrexate or cyclosporine\/mycophenolate mofetil for GVHD prophylaxis after reduced intensity allogeneic stem cell transplantation for patients with lymphoma clinicaltrials.gov\/show\/NCT00928018"},{"issue":"2-3","key":"10.1002\/14651858.CD010280.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010280.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines 3: rating the quality of evidence - introduction","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705488","article-title":"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration","volume":"38","author":"Bensinger","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010280.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbmt.2005.02.006","article-title":"Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens","volume":"11","author":"Cutler","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0019|cit19","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"9674","key":"10.1002\/14651858.CD010280.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD010280.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010280.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010280.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD010280.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - risk of bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD010280.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD010280.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD010280.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD010280.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0031|cit31","unstructured":"Higgins JPT Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0032|cit32","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0033|cit33","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"9","key":"10.1002\/14651858.CD010280.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/bmt.2012.71","article-title":"Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis","volume":"47","author":"Kharfan-Dabaja","year":"2012","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","article-title":"Economics of hematopoietic stem cell transplantation","volume":"120","author":"Khera","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010280.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD010280.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"issue":"22","key":"10.1002\/14651858.CD010280.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0040|cit40","first-page":"2654a","article-title":"Tacrolimus and mycophenolate mofetil for GVHD prevention after unrelated donor transplants","volume":"102","author":"McSweeney","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010280.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbmt.2005.10.012","article-title":"Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation","volume":"12","author":"Nieto","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010280.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbmt.2003.11.005","article-title":"A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients","volume":"10","author":"Osunkwo","year":"2004","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010280.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.bbmt.2010.01.007","article-title":"Glucocorticoid-refractory acute graft-versus-host disease","volume":"16","author":"Pidala","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD010280.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/bmt.2009.362","article-title":"MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings","volume":"45","author":"Pinana","year":"2010","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0045|cit45","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/TP.0b013e31822d880d","article-title":"Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial","volume":"92","author":"Schmeding","year":"2011","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010280.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010280.pub2-BIB0049|cit49","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD010280.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010280.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/01.tp.0000210324.44633.b1","article-title":"Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades","volume":"81","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010280.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/bmt.2011.162","article-title":"Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation","volume":"47","author":"Svahn","year":"2012","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010280.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD010280.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood.V91.7.2581","article-title":"Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts","volume":"91","author":"Yu","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010280.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trre.2009.02.002","article-title":"Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients - a systematic review","volume":"23","author":"Zuk","year":"2009","journal-title":"Transplantation Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010280.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T08:38:15Z","timestamp":1710751095000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010280.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,25]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010280.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,25]]}}}